Boston CEO
Date: Location: Cost:
May 30 - 31, 2017 Four Seasons Boston
200 Boylston Street
Boston, MA 02116
(617) 338-4400

Starting at $1950

 

Dress Code:
Business Attire

Register

Boston CEO - May 30, 2017 - Four Seasons

Co-hosts: Paul Biondi, Suzanne Bruhn, Ron Cooper, Robert Coughlin, Deborah Dunsire, Michael Ehlers, Chris Garabedian, JC Gutierrez-Ramos, William Heiden, Mary Lynne Hedley, Ed Kaye, Jay Luly, Martin Mackay, Sandy Macrae, John Maraganore, David Meek, Paris Panayiotopoulos, Adelene Perkines, Rob Perez, Roger Pomerantz, Ronald Renaud, Al Sandrock, Paula Soteropoulos, Henri Termeer, Roger Tung, Sue Washer, Christoph Westphal

Time Agenda
7:30-8:30 am

Registration and Networking Breakfast

8:30-8:40 am

Welcome and Opening Remarks

8:40-9:00 am

Fireside Chat
Stephen Ostroff
, Acting Commisioner, FDA; Henri Termeer, former CEO, Genzyme
Moderator: Christoph WestphalCo-Founder & Partner, Longwood Fund

9:00-9:30 am

CEO Roundtable
Deborah Dunsire, CEO, XTuit Pharmaceuticals; Geoffrey McDonough, President & CEO, Swedish Orphan Biovitrum; Rob Perez, Founder & Chairman, Life Science Cares; Henri Termeer, former CEO, Genzyme
Moderator: Pierre Jacquet, Managing Director, L.E.K. Consulting

9:30-10:00 am

Healthcare Market Outlook -- 2017 and Beyond
Robert Guidos, Associate Director, Legislative Affairs, FDA; Jeff Leerink, Chairman & CEO, Leerink Partners; Thilo SchroederPartnerNextech Invest; Gary Zieziula, President & Managing Director, EMD Serono
Moderator: Michael Goettler, Global President, Rare Diseases, Pfizer

10:00-10:30 am

Networking Break

10:30-11:00 am

Understanding and Managing Growth
Mary Lynne HedleyCo-founder, President & COO, TESARO; William Heiden, CEO, AMAG Pharmaceuticals; Shalini Sharp, CFO, Ultragenyx
Moderator: Robert Beardsley, COO, Galera Therapeutics

11:00-11:30 am

Diversity: Moving from Sound Bite to Implementation
Jeff Albers, CEO, Blueprint Medicines; Suzanne Bruhn, Board, Aeglea BioTherapeutics; Andi Karaboutis, former EVP, Biogen
Moderator: Cissy Young, Executive Director, Russell Reynolds

11:30-12:00 pm

Ensuring Transparency and Drug Value
Ron Cooper, President & CEO, Albireo; Thomas Lönngrenformer Executive Director, European Medicines Agency; Jay Luly, CEO, Enanta; Ed Mascioli, CEO, Karos Pharmaceuticals

12:00-1:00 pm

Networking Lunch

1:00-1:30 pm

Moderated Keynote
John Barros, Chief of Economic Development, City of Boston
Moderator: Christoph WestphalCo-Founder & Partner, Longwood Fund

1:30-2:00 pm

Accessing Early-Stage Innovation
Ansbert GadickeCo-Founder & Managing Director, MPM Capital; Adi Hoess, CEO, Affimed; Brian McVeighVP, WWBD Transactions & Investment Management, GlaxoSmithKline; Chandra Ramanathan, VP & Head, East Coast Innovation Center, Bayer; Ken Rhodes, CSO, Yumanity

2:00-2:30 pm

Therapeutic Market Focus: Microbiome
Mark Bodmer
, CSO & President of R&D, Evelo Biosciences; Rodolphe Clerval, CBO, Enterome; Todd Krueger, President, AOBiome; Bernat Olle, CEO, Vedanta Biosciences; Jeff Riley, CEO, Synthetic Biologics; Michele Trucksis, CMO, Seres Therapeutics

2:30-3:00 pm

Networking Break

3:00-3:30 pm

Oncology Trends and Predictions
Gil Beyen, Chairman & CEO, Erytech; Roman Fleck, CEO, Janpix; Arthur Krieg, CEO, Checkmate Pharmaceuticals; Jimmy Lin, CSO, Natera; Oliver Rosen, CMO, Deciphera; Patrick TricoliCEO, Nanobiotix US
Moderator: Jeremy Goldberg, Managing Director, Torreya Partners

3:30-4:00 pm

Building a Biotech: Innovative Business Models
Yuval Cohen, CEO, Corbus Pharmaceuticals; Ana Maiques, CEO, Neuroelectrics; Eddie Martucci, Co-Founder & CEO, Akili Interactive; Paula Soteropoulos, CEO, Akcea Therapeutics; Gregory Verdine, Founder, CEO, & CSO, FogPharma
Moderator: JC Gutierrez-RamosCEO, Synlogic Therapeutics

4:00-4:30 pm

Partner or Go it Alone?
Carl Firth, CEO, Aslan Pharmaceuticals; Kia MoteshareiVP & Global Head, BD, Neurology & Immunology, EMD Serono; Tim Noyes, President & CEO, Proteon Therapeutics; Mark Nuttall, Head of MS and Immunology BD&L, Sanofi Genzyme; Leslie Williams, Founder, President & CEO, ImmusanT
Moderator: Michael Bell, Chairman & CEO, inVentiv Health

4:30-5:00 pm

Next Generation Biotech CEOs and Board Members
Nessan Bermingham, President & CEO, Intellia Therapeutics; Nancy Lurker, President & CEO, pSivda; Francois Nader, Chairman, Acceleron Pharma; Rob Perez, Partner, Vineyard Sound Advisors

5:00-6:00 pm

Cocktails and Hors d'oeuvres

May 31, 2017

Co-hosts: Paul Biondi, Suzanne Bruhn, Ron Cooper, Robert Coughlin, Deborah Dunsire, Michael Ehlers, Chris Garabedian, JC Gutierrez-Ramos, William Heiden, Mary Lynne Hedley, Ed Kaye, Jay Luly, Martin Mackay, Sandy Macrae, John Maraganore, David Meek, Paris Panayiotopoulos, Adelene Perkines, Rob Perez, Roger Pomerantz, Ronald Renaud, Al Sandrock, Paula Soteropoulos, Henri Termeer, Roger Tung, Sue Washer, Christoph Westphal

Time Agenda
7:30-8:30 am

Registration and Networking Breakfast

8:30-8:40 am

Welcome and Opening Remarks

8:40-9:10 am

Advances in Personalized Medicine
Arthur Hiller, CEO, Antyllus; Kenneth Moch, President & CEO, Cognition Therapeutics; Joe Payne, President & CEO, Arcturus; Steven Perrin, CEO & CSO, ALS Therapy Development Institute; Al Sandrock, CMO & EVP, Biogen
Moderator: Robert Silverman, Head, Externalized Drug Discovery PartneringRoche

9:10-9:40 am

Small-Cap and Private Biotech: Leveraging Potential
Frederick Beddingfield
President & CEO, Sienna Biopharmaceuticals; Alan Ezekowitz, CEO, Abide Therapeutics; Brian Leuthner, President & CEO, Edge Therapeutics; Dan Swisher, CEO, Sunesis Pharmaceuticals; Ailis Tweed-Kent, Founder & CEO, Cocoon Biotech
Moderator: Gregg BeloffCFO, Centrexion Therapeutics

9:40-10:10 am

Therapeutic Market Focus: Cell & Gene Therapy
Al Gianchetti
, CEO, XyloCor Therapeutics; Ed Kaye, CEO, Sarepta; Jak Knowles, President & CEO, Exonics Therapeutics; Amber Salzman, President & CEO, Adverum Biotechnologies; Pascal TouchonSVP, Global Head Strategy & BD&L, Novartis

10:10-10:40 am

Networking Break

10:40-11:00 am

Fireside Chat
Michael Ehlers
EVP, R&D, Biogen; David Meek, CEO, IPSEN
Moderator: Christoph WestphalCo-Founder & Partner, Longwood Fund

11:00-11:30 am

Accessing Innovation via M&A and Partnerships
Chris Christoffersen, Partner, Lightstone Ventures; Sven Dethlefs, Global Head Respiratory Medicines, Teva; Elcin Ergun, President, New Business, EMD Serono; Cynthia Schwalm, President, North America Commercial Operations, IPSEN
Moderator: Sue WasherPresident & CEO, AGTC

11:30-12:00 pm

Buy or Build?
Grace Colon, CEO, InCarda Therapeutics; John Cox, CEO, Bioverativ; Danguole AltmanPresident & CEO, Vapogenix; Roger Tung, CEO, Concert Pharmaceuticals
Moderator: Steve Cutler, CEO, ICON

12:00-1:00 pm

Networking Lunch

1:00-1:30 pm

Evolving BioPharma Boards
Don deBethizy
, Chairman, Albumedix A/S; James Geraghty, Chairman, Juniper Pharma; David Southwell, President & CEO, Inotek Pharmaceuticals

1:30-2:00 pm

Boston-Bound Biotech and Pharma: Impact on Innovation
Paul BiondiSVP, Head, BD, Bristol-Myers Squibb; Paul Bolno, President & CEO, WaVe Life Sciences; Chris GarabedianChairman & CEO, Xontogeny; Jonathan Lewis, CEO, Samus Therapeutics
Moderator: Bob Coughlin, President & CEOMassBio

2:00-2:30 pm

Global Markets: Biotechs Across Borders
Samatha Du
, Chairperson & CEO, Zai Laboratory; Mary Szela, CEO, Novelion Therapeutics; James Xue, CEO, CANbridge Life Sciences

2:30-3:00 pm

Networking Break

3:00-3:20 pm

Fireside Chat
John Maraganore
, CEO, Alnylam
Moderator: Christoph WestphalCo-Founder & Partner, Longwood Fund

3:20-3:50 pm

Achieving Organizational Turnarounds
Richard Daly
, Chairman & CEO, Neuralstem; Sandy Macrae, CEO, Sangamo Therapeutics; Adelene Perkins, Chairman & CEO, Infinity Pharmaceuticals
Moderator: Paris Panayiotopoulos, President & CEO, ARIAD Pharmaceuticals

3:50-4:20 pm

M&A Activity Post the IPO-Boom: Impact on Fundraising and Dealmaking
Luba Greenwood, VP Global BD & M&A, Roche; John HaurumCEO, F-star Biotechnology; Philippe Lopes-Fernandes, SVP, Global Head, BD & Alliance ManagementEMD Serono

4:20-4:45 pm

Presentation of 2016 Boston CEO Lifetime Achievement Award
Bob Coughlin, 2016 Honoree; John Maraganore, 2015 Honoree

4:45-6:00 pm

Cocktails and Hors d'oeuvres

Premier Sponsors: (see all sponsors)

<